245 related articles for article (PubMed ID: 25846830)
41. Serum Angiogenesis Markers and Their Correlation with Ultrasound-Detected Synovitis in Juvenile Idiopathic Arthritis.
Świdrowska J; Smolewski P; Stańczyk J; Smolewska E
J Immunol Res; 2015; 2015():741457. PubMed ID: 26065004
[TBL] [Abstract][Full Text] [Related]
42. Differentially Expressed Inflammation-Regulating MicroRNAs in Oligoarticular Juvenile Idiopathic Arthritis.
McAlpine SM; Roberts SE; Hargreaves BKV; Bullock C; Ramsey S; Stringer E; Lang B; Huber A; György B; Erdélyi F; Issekutz TB; Dérfalvi B
J Rheumatol; 2023 Feb; 50(2):227-235. PubMed ID: 35840148
[TBL] [Abstract][Full Text] [Related]
43. Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline.
Ganeva M; Fuehner S; Kessel C; Klotsche J; Niewerth M; Minden K; Foell D; Hinze CH; Wittkowski H
Pediatr Rheumatol Online J; 2021 May; 19(1):64. PubMed ID: 33933108
[TBL] [Abstract][Full Text] [Related]
44. IL23R gene polymorphism with juvenile idiopathic arthritis and its association with serum IL-17A.
Emami S; Ziaee V; Rezaei A; Sadr M; Maddah M; Amirzargar AA; Rezaei N
Int J Rheum Dis; 2016 Nov; 19(11):1189-1196. PubMed ID: 26016922
[TBL] [Abstract][Full Text] [Related]
45. HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration.
Schierbeck H; Pullerits R; Pruunsild C; Fischer M; Holzinger D; Laestadius Å; Sundberg E; Harris HE
J Rheumatol; 2013 Sep; 40(9):1604-13. PubMed ID: 23858044
[TBL] [Abstract][Full Text] [Related]
46. JNK Pathway-Associated Phosphatase as a Serum Marker for Disease Activity and Treatment Outcome of Juvenile Idiopathic Arthritis.
Zhu S; Lv H; Luo Y; Huang Q; Shen J
Tohoku J Exp Med; 2021 Jan; 253(1):19-28. PubMed ID: 33441511
[TBL] [Abstract][Full Text] [Related]
47. Concerted Actions by PIICP, CTXII, and TNF-α in Patients with Juvenile Idiopathic Arthritis.
Winsz-Szczotka K; Kuźnik-Trocha K; Lachór-Motyka I; Lemski W; Olczyk K
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33924892
[TBL] [Abstract][Full Text] [Related]
48. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
49. Increased carotid artery intima-media thickness and myeloperoxidase level in children with newly diagnosed juvenile idiopathic arthritis.
Ilisson J; Zagura M; Zilmer K; Salum E; Heilman K; Piir A; Tillmann V; Kals J; Zilmer M; Pruunsild C
Arthritis Res Ther; 2015 Jul; 17(1):180. PubMed ID: 26179062
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
[TBL] [Abstract][Full Text] [Related]
51. Impairment of microcirculation in juvenile idiopathic arthritis - studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF.
Gorska A; Kowal-Bielecka O; Urban M; Chlabicz S; Sienkiewicz J; Gorski S
Folia Histochem Cytobiol; 2008; 46(4):443-7. PubMed ID: 19141396
[TBL] [Abstract][Full Text] [Related]
52. Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis-an explorative cross-sectional study.
Cetrelli L; Lundestad A; Gil EG; Fischer J; Halbig J; Frid P; Angenete O; Rosén A; Tylleskär KB; Luukko K; Nordal E; Åstrøm AN; Skeie MS; Stunes AK; Bletsa A; Sen A; Feuerherm AJ; Rygg M
Pediatr Rheumatol Online J; 2024 Mar; 22(1):36. PubMed ID: 38461338
[TBL] [Abstract][Full Text] [Related]
53. Circulating keratan sulfate as a marker of metabolic changes of cartilage proteoglycan in juvenile idiopathic arthritis; influence of growth factors as well as proteolytic and prooxidative agents on aggrecan alterations.
Winsz-Szczotka K; Komosińska-Vassev K; Kuźnik-Trocha K; Siwiec A; Żegleń B; Olczyk K
Clin Chem Lab Med; 2015 Feb; 53(2):291-7. PubMed ID: 25153398
[TBL] [Abstract][Full Text] [Related]
54. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
[TBL] [Abstract][Full Text] [Related]
55. Influence of proteolytic-antiproteolytic enzymes and prooxidative-antioxidative factors on proteoglycan alterations in children with juvenile idiopathic arthritis.
Winsz-Szczotka K; Komosińska-Vassev K; Kuźnik-Trocha K; Gruenpeter A; Lachór-Motyka I; Olczyk K
Clin Biochem; 2014 Jun; 47(9):829-34. PubMed ID: 24495859
[TBL] [Abstract][Full Text] [Related]
56. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
Viswanath V; Myles A; Dayal R; Aggarwal A
J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
[TBL] [Abstract][Full Text] [Related]
58. Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
Haasnoot AJ; van Tent-Hoeve M; Wulffraat NM; Schalij-Delfos NE; Los LI; Armbrust W; Zuithoff NP; de Boer JH
Am J Ophthalmol; 2015 Feb; 159(2):372-7.e1. PubMed ID: 25447121
[TBL] [Abstract][Full Text] [Related]
59. Association between high mobility group box 1 protein and juvenile idiopathic arthritis: a prospective longitudinal study.
Xu D; Zhang Y; Zhang ZY; Tang XM
Pediatr Rheumatol Online J; 2021 Jul; 19(1):112. PubMed ID: 34247641
[TBL] [Abstract][Full Text] [Related]
60. High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.
Alberdi-Saugstrup M; Zak M; Nielsen S; Herlin T; Nordal E; Berntson L; Fasth A; Rygg M; Klaus Müller ;
Rheumatol Int; 2017 May; 37(5):695-703. PubMed ID: 28283733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
